TITLE

Bone turnover during high dose inhaled corticosteroid treatment

AUTHOR(S)
Ali, N J; Capewell, S; Ward, M J
PUB. DATE
March 1991
SOURCE
Thorax;Mar1991, Vol. 46 Issue 3, p160
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
66015152

 

Related Articles

  • Impact of Inhaled and Intranasal Corticosteroids on the Growth of Children. Wolthers, O.D. // BioDrugs;2000, Vol. 13 Issue 5, p347 

    Since inhaled and intranasal corticosteroids may be systemically bioavailable, risk of growth suppression cannot be ruled out in children treated with these compounds. The mechanisms by which exogenous corticosteroids can cause growth suppression may be multifactorial, involving influences on...

  • Inhaled Corticosteroids, Bone Mineral Density and Fracture in Older People. Hubbard, Richard; Tattersfield, Anne // Drugs & Aging;2004, Vol. 21 Issue 10, p631 

    The efficacy of inhaled corticosteroids in the treatment of asthma has been firmly established in a variety of settings. The majority of asthma management plans now recommend the use of inhaled corticosteroids at an early stage. This means that most patients with asthma will be prescribed an...

  • The use of inhaled corticosteroids during childhood: plus ça change... Russell, G // Archives of Disease in Childhood;Oct2004, Vol. 89 Issue 10, p893 

    The article discusses the use of inhaled corticosteroid therapy (ICT) in the management of asthma during childhood. In recommended doses, ICT has had an excellent safety record, but encouraged by reports of the apparent safety of high dose ICT in adults, paediatricians became increasingly bold...

  • Corticosteroids and bone mass in asthma: comparisons with rheumatoid arthritis and polymyalgia rheumatica. Reid, D.M.; Nicoll, J.J.; Smith, M.A.; Higgins, B.; Tothill, P.; Nuki, G. // British Medical Journal (Clinical Research Edition);12/6/1986, Vol. 293 Issue 6560, p1463 

    Examines on corticosteroids and bone mass in asthma. Comparisons with rheumatoid arthritis and polymyalgia rheumatica; Analysis of patients as recipients of treatments for asthma; Reduction of body calcium in patients inhaled corticosteroids; Assessment of losses of bone associated with the...

  • Clinical Safety of Inhaled Corticosteroids for Asthma in Children: An Update of Long-Term Trials. Pedersen, Søren // Drug Safety;2006, Vol. 29 Issue 7, p599 

    Inhaled corticosteroids are established as the mainstay of maintenance therapy for chronic asthma. However, there remains some debate regarding the safety of long-term use of these agents, particularly in children. This concern mainly stems from the findings of short-term studies assessing the...

  • Inhaled corticosteroids may carry less risk of BMD reduction in postmenopausal women.  // Formulary;Apr2003, Vol. 38 Issue 4, p193 

    Discusses the results of a study showing that moderate doses of inhaled corticosteroids carry less risk than traditional oral corticosteroid therapy with respect to reduction of bone mineral density (BMD) in post-menopausal women. Overview of the study; Effect of oral glucocorticoid treatment...

  • High dose inhaled steroids and bone turnover elderly asthmatics. Lawson-Matthew, P.J.; Gordon, S. // Age & Ageing;Sep96 Supplement, Vol. 25, p14 

    Presents an abstract of the study `High Dose Inhaled Steroids and Bone Turnover in Elderly Asthmatics,' by P.J. Lawson-Matthew, S. Gordon and A.H. Morice, presented during the Communications to the Spring Meeting of the British Geriatrics Society on April 11-13, 1996 in Canterbury, England.

  • Asthma in Pregnancy. Nelson-Piercy, C. // Thorax;Apr2001, Vol. 56 Issue 4, p325 

    The article focuses on the management of asthma disease in pregnancy. The drug treatment of asthma includes agonists, inhaled corticosteroids, methyl xanthines, leukotriene antagonists are safe in pregnancy. Fluticasone may be used for those requiring high doses of inhaled steroids. Great...

  • Asthma medications and their potential adverse effects in the elderly: recommendations for prescribing. Newnham, D.M. // Drug Safety;Nov2001, Vol. 24 Issue 14, p1065 

    The incidence of drug-induced adverse effects is likely to increase as a result of advanced age and exposure of elderly patients to polypharmacy. Therefore, pharmacological therapy of asthma and chronic obstructive pulmonary disease (COPD) in the elderly patient can be potentially hazardous....

  • Purpura and dermal thinning associated with high dose inhaled corticosteroids. Capewell, S.; Reynolds, S.; Shuttleworth, D.; Edwards, C.; Finlay, A.Y. // BMJ: British Medical Journal (International Edition);6/16/90, Vol. 300 Issue 6739, p1548 

    Assesses the effects of inhaled corticosteroids on skin. Occurrence of thinner skin on corticosteroid treated group; Prevalence of purpura in persons having prednisolone; Association between high dose inhaled corticosteroid and skin thinning and purpura.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics